3-[2-(3-hydroxyphenyl)-1-methylpropyl]phenol (meso form)

ID: ALA279151

Chembl Id: CHEMBL279151

Cas Number: 68266-23-9

PubChem CID: 326250

Max Phase: Preclinical

Molecular Formula: C16H18O2

Molecular Weight: 242.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: NSC-297169 | 3-[3-(3-hydroxyphenyl)butan-2-yl]phenol|68266-23-9|NSC-297169|CHEMBL279151|SCHEMBL11619117|DTXSID80315760|NSC297169

Canonical SMILES:  CC(c1cccc(O)c1)C(C)c1cccc(O)c1

Standard InChI:  InChI=1S/C16H18O2/c1-11(13-5-3-7-15(17)9-13)12(2)14-6-4-8-16(18)10-14/h3-12,17-18H,1-2H3

Standard InChI Key:  NVDZTIMKHYWAEW-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Esr1 Estrogen receptor (1901 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Esr2 Estrogen receptor (2172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Estrogen receptor (627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rmlD dTDP-4-dehydrorhamnose reductase (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 242.32Molecular Weight (Monoisotopic): 242.1307AlogP: 4.01#Rotatable Bonds: 3
Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.77CX Basic pKa: CX LogP: 4.48CX LogD: 4.47
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.85Np Likeness Score: 0.25

References

1. Hartmann RW, Buchborn H, Kranzfelder G, Schönenberger H, Bogden A..  (1981)  Potential antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,2-dialkyl-1,2-bis(3'-hydroxyphenyl)ethanes.,  24  (10): [PMID:6276542] [10.1021/jm00142a014]
2. Hartmann RW, Heindl A, Schwarz W, Schönenberger H..  (1984)  Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.,  27  (7): [PMID:6330356] [10.1021/jm00373a001]
3. Elam C, Lape M, Deye J, Zultowsky J, Stanton DT, Paula S..  (2011)  Discovery of novel SERCA inhibitors by virtual screening of a large compound library.,  46  (5): [PMID:21353727] [10.1016/j.ejmech.2011.01.069]
4. Wang Y, Hess TN, Jones V, Zhou JZ, McNeil MR, Andrew McCammon J..  (2011)  Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.,  21  (23): [PMID:22014548] [10.1016/j.bmcl.2011.09.094]

Source